lorazepam has been researched along with Anankastic Personality in 11 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Hyperactivity, impulsivity, and inattention improved with lorazepam, suggesting that the attention-deficit/hyperactivity disorder symptoms could be manifestations of catatonia." | 7.73 | PANDAS with catatonia: a case report. Therapeutic response to lorazepam and plasmapheresis. ( Ahmed, AA; Balamuth, N; Dell, ML; Elia, J; Friedman, DF; Pati, S; Zimmerman, RA, 2005) |
| " Week 2 dosage was increased, decreased, or maintained depending on response and side effects." | 6.71 | Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder. ( Aboujaoude, E; Bullock, KD; Elliott, M; Franz, B; Gamel, N; Koran, LM, 2005) |
| "Catatonia is a syndrome with protean manifestations and multiple aetiologies." | 5.37 | Chronic catatonia with obsessive compulsive disorder symptoms treated with lorazepam, memantine, aripiprazole, fluvoxamine and neurosurgery. ( Jean-Baptiste, M; Mukai, Y; Two, A, 2011) |
| " Here, we report a case of the use of the benzodiazepine antagonist flumazenil before ECT to facilitate the simultaneous use of lorazepam and ECT for the treatment of co-occurring catatonia and obsessive-compulsive disorder." | 3.78 | Successful treatment of co-occurring catatonia and obsessive-compulsive disorder with concurrent electroconvulsive therapy and benzodiazepine administration. ( Furst, BA; Kwon, GE; Makhinson, M; Shuff, MK, 2012) |
| " Hyperactivity, impulsivity, and inattention improved with lorazepam, suggesting that the attention-deficit/hyperactivity disorder symptoms could be manifestations of catatonia." | 3.73 | PANDAS with catatonia: a case report. Therapeutic response to lorazepam and plasmapheresis. ( Ahmed, AA; Balamuth, N; Dell, ML; Elia, J; Friedman, DF; Pati, S; Zimmerman, RA, 2005) |
| " Week 2 dosage was increased, decreased, or maintained depending on response and side effects." | 2.71 | Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder. ( Aboujaoude, E; Bullock, KD; Elliott, M; Franz, B; Gamel, N; Koran, LM, 2005) |
| "Catatonia is a syndrome with protean manifestations and multiple aetiologies." | 1.37 | Chronic catatonia with obsessive compulsive disorder symptoms treated with lorazepam, memantine, aripiprazole, fluvoxamine and neurosurgery. ( Jean-Baptiste, M; Mukai, Y; Two, A, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Nikjoo, A | 1 |
| Wright, C | 1 |
| Kheriaty, A | 1 |
| Van Ameringen, M | 1 |
| Patterson, B | 1 |
| Mukai, Y | 1 |
| Two, A | 1 |
| Jean-Baptiste, M | 1 |
| Makhinson, M | 1 |
| Furst, BA | 1 |
| Shuff, MK | 1 |
| Kwon, GE | 1 |
| Matthews, A | 1 |
| Kirkby, KC | 1 |
| Martin, F | 1 |
| Koran, LM | 1 |
| Aboujaoude, E | 1 |
| Bullock, KD | 1 |
| Franz, B | 1 |
| Gamel, N | 1 |
| Elliott, M | 1 |
| Elia, J | 1 |
| Dell, ML | 1 |
| Friedman, DF | 1 |
| Zimmerman, RA | 1 |
| Balamuth, N | 1 |
| Ahmed, AA | 1 |
| Pati, S | 1 |
| Göder, R | 1 |
| Friege, L | 1 |
| Treskov, V | 1 |
| Grohmann, R | 1 |
| Aldenhoff, JB | 1 |
| Carmin, CN | 1 |
| Wiegartz, PS | 1 |
| Yunus, U | 1 |
| Gillock, KL | 1 |
| Dubnitskaia, EB | 1 |
| Basov, AM | 1 |
| Bodkin, JA | 1 |
| White, K | 1 |
3 trials available for lorazepam and Anankastic Personality
| Article | Year |
|---|---|
The effects of single-dose lorazepam on memory and behavioural learning.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Female; Hand Disinfection; Humans; Learning; Lorazepam; Male | 2002 |
Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder.
Topics: Administration, Oral; Adult; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combin | 2005 |
[Use of phenazepam in the treatment of neurotic conditions].
Topics: Adult; Affective Symptoms; Anti-Anxiety Agents; Benzodiazepines; Chemical Phenomena; Chemistry; Clin | 1978 |
8 other studies available for lorazepam and Anankastic Personality
| Article | Year |
|---|---|
A Case Report of Scrupulosity Presenting as Catatonia in a Patient With Both OCD and OCPD.
Topics: Catatonia; Depressive Disorder, Major; Female; Humans; Lorazepam; Obsessive-Compulsive Disorder | 2022 |
Topiramate augmentation in a patient with obsessive-compulsive disorder.
Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Citalopram; Drug Synergism; Fear; Female; Fructose; Hum | 2015 |
Chronic catatonia with obsessive compulsive disorder symptoms treated with lorazepam, memantine, aripiprazole, fluvoxamine and neurosurgery.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Catatonia; Chronic Disease; Combined Modality Therapy; Do | 2011 |
Successful treatment of co-occurring catatonia and obsessive-compulsive disorder with concurrent electroconvulsive therapy and benzodiazepine administration.
Topics: Adult; Benzodiazepines; Catatonia; Combined Modality Therapy; Depressive Disorder, Major; Electrocon | 2012 |
PANDAS with catatonia: a case report. Therapeutic response to lorazepam and plasmapheresis.
Topics: Attention Deficit Disorder with Hyperactivity; Autoimmune Diseases; Basal Ganglia Diseases; Catatoni | 2005 |
Association of paroxetine with suicide attempt in obsessive-compulsive disorder.
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Humans; Lorazepam; Male; Methotrimeprazine; Obsess | 2000 |
Treatment of late-onset OCD following basal ganglia infarct.
Topics: Aged; Basal Ganglia Cerebrovascular Disease; Cerebral Infarction; Cognitive Behavioral Therapy; Comb | 2002 |
Clonazepam in the treatment of obsessive compulsive disorder associated with panic disorder in one patient.
Topics: Adult; Anxiety Disorders; Clonazepam; Fear; Humans; Lorazepam; Male; Obsessive-Compulsive Disorder; | 1989 |